1196909

AmbioPharm, Inc — FEI 3006446551

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 9, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Beech Island, SC (United States)